Kenalog and Ranitidine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Ranitidine hydrochloride (ranitidine hydrochloride). Common drug interactions include macular degeneration among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Ranitidine hydrochloride. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

On Jul, 11, 2026

17 people who take Kenalog and Ranitidine hydrochloride together, and have interactions are studied.

Kenalog and Ranitidine hydrochloride drug interactions.

What are the common drug interactions of Kenalog and Ranitidine Hydrochloride, by gender? *:

female:

Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Pruritus (severe itching of the skin)
Schizoaffective disorder (a mental disorder characterized by disordered thought)
Gingivitis (inflammation of gums)
Osteitis (a general term for inflammation of bone)
Osteonecrosis (death of bone)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Postoperative wound complication
Proteinuria (presence of protein in the urine)
Sensation of foreign body

male:

Chronic kidney disease
Renal failure (kidney dysfunction)

What are the common drug interactions of Kenalog and Ranitidine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Chronic kidney disease
Aphthous stomatitis (mouth ulcer)
Proteinuria (presence of protein in the urine)
Renal failure (kidney dysfunction)
Tongue neoplasm malignant stage unspecified
Blood glucose decreased
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Therapeutic response unexpected
Gingivitis (inflammation of gums)
Osteitis (a general term for inflammation of bone)

What are the existing conditions these people have? *

Gastritis (inflammation of stomach): 4 people, 23.53%
Osteoporosis (bones weak and more likely to break): 4 people, 23.53%
Rashes (redness): 4 people, 23.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 23.53%
Diabetic Nephropathy (diabetic kidney disease): 3 people, 17.65%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 17.65%
Constipation: 3 people, 17.65%
Ear Pain: 3 people, 17.65%
Gastric Ulcer (stomach ulcer): 2 people, 11.76%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Ranitidine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously